Sofosbuvir/ledipasvir plus vedroprevir shows 96% response rate for hard-to-treat genotype 1 hepatitis C patients

Press/Media: Press / Media

PeriodNov 18 2015

Media coverage

1

Media coverage

  • TitleSofosbuvir/ledipasvir plus vedroprevir shows 96% response rate for hard-to-treat genotype 1 hepatitis C patients
    Media name/outletAidsmap
    CountryUnited Kingdom
    Date11/18/15
    PersonsEric J Lawitz